Engaged in the discovery and development of diagnostic solutions, particularly focused on early cancer detection using proprietary biomarker technologies.
2007
Sweden
11 - 50 employees
Biotechnology
$0 - 100K in revenue
Not profitable
CO2e per visit (g)
Industry benchmark
Total Annual
Revenue & EBITDA
($ B)
Margin as % of revenue
R&D as % of revenue
Analyst consensus vs actuals
($ B)
0.0
▼ 98.6%
0.1
2029| Target | Year | Value | Scope | Baseline |
|---|
Not available
Not available
Not available
Not available
6 out of 7 incl. management
Not available
Not available
Not available
Not available
Not available
Not available
Not available